109 related articles for article (PubMed ID: 12775610)
1. NICE recommends new treatment for breast and bowel cancer.
Mayor S
BMJ; 2003 May; 326(7400):1166. PubMed ID: 12775610
[No Abstract] [Full Text] [Related]
2. Drug combination approved for advanced breast cancer.
FDA Consum; 2002; 36(1):5. PubMed ID: 11881602
[No Abstract] [Full Text] [Related]
3. Combination versus sequential single-agent therapy in metastatic breast cancer.
Miles D; von Minckwitz G; Seidman AD
Oncologist; 2002; 7 Suppl 6():13-9. PubMed ID: 12454315
[TBL] [Abstract][Full Text] [Related]
4. Applications of oral fluoropyrimidines in colon cancer: their role and new directions.
Benson AB
J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-17-21. PubMed ID: 23570133
[No Abstract] [Full Text] [Related]
5. Xeloda and Taxotere: a review of the development of the combination for use in metastatic breast cancer.
McDonald F; Miles D
Int J Clin Pract; 2003; 57(6):530-4. PubMed ID: 12918893
[TBL] [Abstract][Full Text] [Related]
6. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
Cunningham D; Coleman R
Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced disease and new drugs.
Frustaci S; Buonadonna A; La Mura N; Berretta M; De Paoli A
Suppl Tumori; 2003; 2(5):S48-50. PubMed ID: 12914391
[No Abstract] [Full Text] [Related]
8. From the Food and Drug Administration.
Schwetz BA
JAMA; 2001 Nov; 286(17):2085. PubMed ID: 11694130
[No Abstract] [Full Text] [Related]
9. [Docetaxel hydrate for treatment of advanced breast cancers].
Fujii H
Nihon Rinsho; 2000 Apr; 58 Suppl():254-8. PubMed ID: 11026003
[No Abstract] [Full Text] [Related]
10. Taxoids in combination chemotherapy for metastatic breast cancer.
Dieras V; Fumoleau P; Bourgeois H; Misset JL; Azli N; Pouillart P
Anticancer Drugs; 1996 Aug; 7 Suppl 2():47-52. PubMed ID: 8862712
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel and paclitaxel in breast cancer therapy: present status and future prospects.
D'Andrea GM; Seidman AD
Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-27-S13-44. PubMed ID: 9335514
[TBL] [Abstract][Full Text] [Related]
12. Improved survival in advanced breast cancer with docetaxel and capecitabine in combination: biological synergy or an artefact of trial design?
Wright TL; Twelves CJ
Eur J Cancer; 2002 Oct; 38(15):1957-60. PubMed ID: 12376198
[No Abstract] [Full Text] [Related]
13. Taxanes in the treatment of breast cancer: a prodigy comes of age.
Miller KD; Sledge GW
Cancer Invest; 1999; 17(2):121-36. PubMed ID: 10071597
[TBL] [Abstract][Full Text] [Related]
14. The necessity of chemotherapy in T3N0M0 colon cancer without risk factors.
Yun HR; Kim HC; Lee WY; Cho YB; Yun SH; Chun HK
Am J Surg; 2009 Sep; 198(3):354-8. PubMed ID: 19716883
[TBL] [Abstract][Full Text] [Related]
15. [5 -fluoropyrimidines for treatment of biliary tract cancers].
Morizane C; Okusaka T; Ueno H; Ikeda M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():529-33. PubMed ID: 16457319
[No Abstract] [Full Text] [Related]
16. [Oral fluoropyrimidines in the treatment of colorectal carcinoma].
Porschen R
Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344
[No Abstract] [Full Text] [Related]
17. Introduction: taxoids and the management of breast cancer.
Hortobagyi GN
Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-1-S13-2. PubMed ID: 9335510
[No Abstract] [Full Text] [Related]
18. Review of recent trials of chemotherapy for advanced breast cancer: the taxanes.
Clemons M; Leahy M; Valle J; Jayson G; Ranson M; Howell A
Eur J Cancer; 1997 Nov; 33(13):2183-93. PubMed ID: 9470804
[No Abstract] [Full Text] [Related]
19. [Docetaxel symposium].
Viens P
Bull Cancer; 1997 Aug; 84(8):833-4. PubMed ID: 9339190
[No Abstract] [Full Text] [Related]
20. [Progress and perspectives in palliative therapy of breast carcinoma].
Verlag GT
Dtsch Med Wochenschr; 1996 Dec; 121(49 Suppl):1-8. PubMed ID: 8983911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
